Noxxon Pharma appoints new chief business officer
This article was originally published in Scrip
Executive Summary
Noxxon Pharma, the German company focused on the development of mirror image oligonucleotide therapeutics called Spiegelmers, has appointed Dr Aram Mangasarian as chief business officer. Dr Mangasarian will be responsible for corporate and business development activities for Noxxon.